Previous 10 | Next 10 |
home / stock / tevjf / tevjf news
Miller Value Partners is a value investor. It values businesses, and not just stocks, and invests in them for the long term. Miller Opportunity Equity was down 31.8% net of fees in first half. We see many compelling opportunities we think can do well irrespective of the macro. ...
David Abrams’ 13F portfolio value decreased this quarter from $4.56B to $4.28B. The number of positions remained steady at 18. Abrams Capital Management increased Coupang and Cantaloupe while reducing AMERCO during the quarter. The top three positions are Lithia Motors, Alp...
The following slide deck was published by Teva Pharmaceutical Industries Limited in conjunction with their 2022 Q1 earnings call. For further details see: Teva Pharmaceutical Industries Limited 2022 Q1 - Results - Earnings Call Presentation
Teva Pharmaceutical Industries Limited (TEVA) Q1 2022 Results Conference Call May 03, 2022 08:00 AM ET Company Participants Ran Meir - Head, IR Kåre Schultz - CEO Eli Kalif - CFO Sven Dethlefs - Head, North America Commercial Conference Call Participants Balaji Prasad - Barclays David Am...
David Abrams’ 13F portfolio value decreased marginally this quarter from $4.59B to $4.56B. The number of positions remained steady at 18. Abrams Capital Management increased Coupang while reducing AMERCO during the quarter. The top three positions are Lithia Motors, Alphabe...
Berkshire Hathaway's 13F stock portfolio value increased from ~$293B to ~$331B. Their largest three holdings are at over two-thirds of the entire portfolio. Berkshire Hathaway increased Chevron while reducing AbbVie, Marsh & McLennan, Bristol-Myers Squibb, Visa, and Royalty Ph...
The following slide deck was published by Teva Pharmaceutical Industries Limited in conjunction with their 2021 Q4 earnings call. For further details see: Teva Pharmaceutical Industries Limited 2021 Q4 - Results - Earnings Call Presentation
Teva Pharmaceutical Industries Ltd. (TEVA) Q4 2021 Results Conference Call February 09, 2022 08:00 AM ET Company Participants Ran Meir - SVP, Head IR Kåre Schultz - CEO Eli Kalif - CFO Sven Dethlefs - Head, North America Commercial Conference Call Participants Umer Raffat - Evercore Ronn...
BDSI prevailed against Alvogen in the invalidity lawsuit. BDSI also provided guidance updates. The Alvogen issue seems settled for now. For further details see: BioDelivery Sciences: Favorable Court Ruling Provides Tailwind
A quality safe and growing dividend is a primary goal for a stock inclusion in “RIG” /Rose’s Income Garden. High Yield “HY” stocks being lucrative are also desired to be safe along with knowing more risk might be involved with lower dividend growth. ...
News, Short Squeeze, Breakout and More Instantly...
Teva Pharmaceutical Industries Ltd Company Name:
TEVJF Stock Symbol:
OTCMKTS Market:
Teva Pharmaceutical Industries Ltd Website: